Curie Institute
Also known as: Institut Curie | Institut Curie - Hopital Rene Huguenin | Institut Curie - Hopital Rene Huguenin - Saint-Cloud - France | INSTITUT CURIE - Hospital | INSTITUT CURIE - Medical Oncology | Institut Curie Paris | Institut Curie, Paris (FR) | Institut Curie - Paris - France | Institut Curie Paris, France | Institut Curie, Paris, France | INSTITUT CURIE, PARIS france | Institut Curie Saint-Cloud | Institut Curie, Saint Cloud | Institut Curie site de Saint Cloud | Institut Curie Site Saint Cloud | institute Curie | Maria Sklodowska-Curie National Research Institute of Oncology | Maria Skłodowska-Curie National Research Institute of Oncology
Highest phase reached
Phase 4
First clinical trial
Dec 1, 1999Last known activity
Dec 5, 2025
Timeline
1920s
- Jun 1, 1920
Curie Institute— Founded
Drugs by trial phase (108 distinct, 97 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (30 own, 0 via acquisition)
Phase 2 (72 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Anus Neoplasms
- Brain Neoplasms
- Breast Neoplasms
- Carcinoma
- Carcinoma, Ovarian Epithelial
- Carcinoma, Squamous Cell
- Carcinoma, Transitional Cell
- Central Nervous System Neoplasms
- Chordoma
- Colorectal Neoplasms
- Depression
- Esophageal Neoplasms
- Fallopian Tube Neoplasms
- Kidney Neoplasms
- Leukemia
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Lymphoma
- Lymphoma, Large B-Cell, Diffuse
- Malnutrition
- Medulloblastoma
- Melanoma
- Meningeal Carcinomatosis
- Meningitis
- Multiple Myeloma
- Myelodysplastic Syndromes
- Myoclonus
- Neoplasm Metastasis
- Neoplasms
- Neoplasms, Glandular and Epithelial
- Neoplasms, Plasma Cell
- Neoplastic Cells, Circulating
- Nervous System Neoplasms
- Neuroblastoma
- Neurotoxicity Syndromes
- Ocular Motility Disorders
- Opsoclonus-Myoclonus Syndrome
- Osteosarcoma
- Ovarian Neoplasms
- Penile Neoplasms
- Peritoneal Neoplasms
- Pleural Effusion
- Pleural Effusion, Malignant
- Postoperative Pain
- Preleukemia
- Prostatic Neoplasms
- Recurrence
- Retinal Neoplasms
- Retinoblastoma
- Sarcoma, Ewing
- Squamous Cell Carcinoma of Head and Neck
- Stomach Neoplasms
- Syndrome
- Thymoma
- Thymus Neoplasms
- Triple Negative Breast Neoplasms
- Ureteral Neoplasms
- Urinary Bladder Neoplasms
- Uterine Cervical Neoplasms
- Uveal Neoplasms
- Vulvar Neoplasms
- Wounds and Injuries
Recent trials (50)
- NCT07193394OfficialPhase 2Dec 5, 2025
- NCT07193394Lead sponsorPhase 2Dec 5, 2025
- NCT07237256OfficialPhase 3Dec 1, 2025
- NCT06625970OfficialPhase 3Jan 31, 2025
- NCT06659705Lead sponsorPhase 2Jan 30, 2025
- NCT06659705OfficialPhase 2Jan 30, 2025
- NCT06558604OfficialPhase 2Dec 31, 2024
- NCT06653777OfficialPhase 2Dec 15, 2024
- NCT06449781Lead sponsorPhase 2Jun 30, 2024
- NCT06337630Lead sponsorPhase 1Jun 15, 2024
- NCT06472583Lead sponsorPhase 2Apr 11, 2024
- NCT06472583OfficialPhase 2Apr 11, 2024
- NCT05973864Overall official - principal investigatorPhase 3Jan 31, 2024
- NCT06199453Lead sponsorPhase 2Jan 31, 2024
- NCT06162351Lead sponsorPhase 2Jan 15, 2024
Details
- Founded
- Paris, FR Jun 1, 1920
- Last known activity
- Dec 5, 2025